LEVY Health has a clear mission: to close the gender health gap and help women who want to conceive. The Berlin-based startup has just picked up €2.5 million to do so, in a round led by Atlantic labs.
The round was accompanied by Austrian VC Calm Storm (heyvie, Keleya). A number of angel investors participated as well, of which 60% are women, including Lea von Bidder (AVA), Jenny Saft (OVIAVO), Hansi Hansmann and Marie-Sophie von Bibra (Readly).
The female-led company has developed CE-compliant software to decipher women’s fertility, helping women who want to have children decode their fertility as quickly as possible. The 3 founders – Theresa Vilsmaier, MD, Silvia Hecher and Caroline Mitterdorfer – developed the LEVY Fertility Code based on clinical guidelines from the EU and US. We actually put the founders on our list of 100 inspirational women in the startup space this year, due to their commitment to using tech for social good.
Caroline Mitterdorfer, Co-Founder and CEO of LEVY Health said: “We are proud that we can now help women who want to have children both decode their fertility and show them how to boost their chances of conceiving with the LEVY Fertility Code. Thank you to all our new and old partners for their support and for joining us on our mission to fight for better women’s healthcare.”
It’s believed that every 7th couple struggles to conceive, and there’s no doubt that fertility is still a taboo topic in society. Further, it creates a massive emotional, physical and financial burden on those affected. Fertility treatments, though, have remained complex with access to fertility specialists hard to come across for many women. This is where LEVY want to shake things up.
LEVY Health is the first company in the world to develop a licensed medical product that analyzes female fertility disorders. The software has been available in Germany since the end of January and helps women and couples find out why they have not been able to get pregnant yet. Based on the results, users are given personalized therapy recommendations. LEVY Health looks at each woman, her body and her situation individually, bringing holistic reproductive medicine straight to users’ homes.
Christophe Maire, Founding Partner Atlantic Labs commented: “With medical precision diagnostics and individualized therapy plans, LEVY is revolutionizing the way infertility is dealt with, helping people conceive and become parents.
We are very impressed by Caroline, Silvia and Theresa – there is hardly anyone who understands the perspectives of different stakeholders so well and combines them so strongly. We have been involved in the FemTech space for quite some time and have had very good experiences with companies like Clue and OVIAVO.”